1-9 of 9
Bart Keymeulen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

74-OR: ADA Presidents' Select Abstract: CGM Metrics from Five Studies Identify Participants at High Risk of Imminent Type 1 Diabetes (T1D) Development

PETER CALHOUN, CHARLEY SPANBAUER, ANDREA STECK, BRIGITTE I. FROHNERT, MARK A. HERMAN, BART KEYMEULEN, SR., RIITTA VEIJOLA, JORMA TOPPARI, ASTER DESOUTER, FRANS K. GORUS, MARK A. ATKINSON, DARRELL M. WILSON, SUSAN PIETROPAOLO, ROY BECK
Journal: Diabetes
Diabetes 2024;73(Supplement_1):74-OR
https://doi.org/10.2337/db24-74-OR
Published: 21 June 2024
View article titled, 74-OR: ADA Presidents' Select Abstract: CGM Metrics from Five Studies Identify Participants at High Risk of Imminent Type 1 Diabetes (T1D) Development
Meeting Abstracts

646-P: Sustained Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring in Adults with Type 1Diabetes: 24-Month Results of the ALERTT1 Trial

MARGARETHA M. VISSER, SARA CHARLEER, STEFFEN FIEUWS, CHRISTOPHE DE BLOCK, ROBERT HILBRANDS, LIESBETH VAN HUFFEL, TOON MAES, GERD VANHAVERBEKE, EVELINE L. DIRINCK, NELE MYNGHEER, CHRIS F. VERCAMMEN, FRANK NOBELS, BART KEYMEULEN, CHANTAL MATHIEU, PIETER GILLARD
Journal: Diabetes
Diabetes 2022;71(Supplement_1):646-P
https://doi.org/10.2337/db22-646-P
Published: 01 June 2022
View article titled, 646-P: Sustained Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring in Adults with Type 1Diabetes: 24-Month Results of the ALERTT1 Trial
Meeting Abstracts

196-LB: Stem Cell–Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide in Patients with Type 1 Diabetes (T1D) and Hypoglycemia Unawareness

BART KEYMEULEN, DANIEL JACOBS-TULLENEERS-THEVISSEN, SR., EVERT J. KROON, MANASI S. JAIMAN, MARK DANIELS, RICHARD WANG, DANIEL PIPELEERS, KEVIN D’AMOUR, HOWARD L. FOYT
Journal: Diabetes
Diabetes 2021;70(Supplement_1):196-LB
https://doi.org/10.2337/db21-196-LB
Published: 01 June 2021
View article titled, 196-LB: Stem Cell–Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide in Patients with Type 1 Diabetes (T1D) and Hypoglycemia Unawareness
Meeting Abstracts

249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes

EMANUELE BOSI, PAOLO POZZILLI, FRANCESCO GIORGINO, EFISIO COSSU, THOMAS LINN, LUDGER ROSE, BART KEYMEULEN, SR., PIETER GILLARD, LUISA DAFFONCHIO, PIER A. RUFFINI, MARCELLO ALLEGRETTI, LORENZO PIEMONTI
Journal: Diabetes
Diabetes 2020;69(Supplement_1):249-OR
https://doi.org/10.2337/db20-249-OR
Published: 01 June 2020
View article titled, 249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes
Journal Articles

Increase Functional β-Cell Mass in Subcutaneous Alginate Capsules With Porcine Prenatal Islet Cells but Loss With Human Adult Islet Cells

Ines De Mesmaeker, Thomas Robert, Krista G. Suenens, Geert M. Stangé, Freya Van Hulle, Zhidong Ling, Peter Tomme, Daniel Jacobs-Tulleneers-Thevissen, Bart Keymeulen, Daniel G. Pipeleers
Journal: Diabetes
Diabetes 2018;67(12):2640–2649
https://doi.org/10.2337/db18-0709
Published: 10 October 2018
View article titled, Increase Functional β-Cell Mass in Subcutaneous Alginate Capsules With Porcine Prenatal Islet Cells but Loss With Human Adult Islet Cells
Open the PDF for Increase Functional β-Cell Mass in Subcutaneous Alginate Capsules With Porcine Prenatal Islet Cells but Loss With Human Adult Islet Cells in another window
Includes: Supplementary data
Journal Articles

Potential of Protein Phosphatase Inhibitor 1 As Biomarker of Pancreatic β-Cell Injury In Vitro and In Vivo

Lei Jiang, Benedicte Brackeva, Zhidong Ling, Gertjan Kramer, Johannes M. Aerts, Frans Schuit, Bart Keymeulen, Daniel Pipeleers, Frans Gorus, Geert A. Martens
Journal: Diabetes
Diabetes 2013;62(8):2683–2688
https://doi.org/10.2337/db12-1507
Published: 17 July 2013
View article titled, Potential of Protein Phosphatase Inhibitor 1 As Biomarker of Pancreatic β-Cell Injury In Vitro and In Vivo
Open the PDF for Potential of Protein Phosphatase Inhibitor 1 As Biomarker of Pancreatic β-Cell Injury In Vitro and In Vivo in another window
Includes: Supplementary data
Journal Articles

Simultaneous Detection of Circulating Autoreactive CD8+ T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers

Jurjen H. Velthuis, Wendy W. Unger, Joana R.F. Abreu, Gaby Duinkerken, Kees Franken, Mark Peakman, Arnold H. Bakker, Sine Reker-Hadrup, Bart Keymeulen, Jan Wouter Drijfhout, Ton N. Schumacher, Bart O. Roep
Journal: Diabetes
Diabetes 2010;59(7):1721–1730
https://doi.org/10.2337/db09-1486
Published: 31 March 2010
View article titled, Simultaneous Detection of Circulating Autoreactive CD8<sup>+</sup> T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers
Open the PDF for Simultaneous Detection of Circulating Autoreactive CD8<sup>+</sup> T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers in another window
Includes: Supplementary data
Journal Articles

Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients

Robert Hilbrands, Volkert A.L. Huurman, Pieter Gillard, Jurjen H.L. Velthuis, Marc De Waele, Chantal Mathieu, Leonard Kaufman, Miriam Pipeleers-Marichal, Zhidong Ling, Babak Movahedi, Daniel Jacobs-Tulleneers-Thevissen, Diethard Monbaliu, Dirk Ysebaert, Frans K. Gorus, Bart O. Roep, Daniel G. Pipeleers, Bart Keymeulen
Journal: Diabetes
Diabetes 2009;58(10):2267–2276
https://doi.org/10.2337/db09-0160
Published: 14 July 2009
View article titled, Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients
Open the PDF for Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients in another window
Includes: Supplementary data
Journal Articles

Long-Term Metabolic Control by Rat Islet Grafts Depends on the Composition of the Implant

Bart Keymeulen, Greg Korbutt, Monique De Paepe, Frans Gorus, Gönter Klöppel, Daniel G Pipeleers
Journal: Diabetes
Diabetes 1996;45(12):1814–1821
https://doi.org/10.2337/diab.45.12.1814
Published: 01 December 1996
View article titled, Long-Term Metabolic Control by Rat Islet Grafts Depends on the Composition of the Implant
Open the PDF for Long-Term Metabolic Control by Rat Islet Grafts Depends on the Composition of the Implant in another window